Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis.

Antonio TravaglinoAntonio RaffoneDiego RaimondoSabrina ReppucciaAlessandro RuggieroAlessandro ArenaPaolo CasadioFulvio ZulloLuigi InsabatoRenato SeracchioliAntonio Mollo

Published in: Archives of gynecology and obstetrics (2022)

CTNNB1 mutation is significantly associated with recurrence in early stage endometrioid endometrial carcinomas, especially in the NSMP, appearing potentially useful in directing adjuvant treatment.

Keyphrases

early stage
endometrial cancer
sentinel lymph node
high grade
combination therapy
lymph node
replacement therapy